 |
Liposome encapsulated recombinant interleukin-2 |
|---|---|
| Trade Name | |
| Orphan Indication | Brain and CNS tumors |
| USA Market Approval | USA |
| USA Designation Date | 1991-11-25 00:00:00 |
| Sponsor | Oncothyreon Canada, Inc.;2011-94 St., NW, Suite 200; |
| |
Liposome encapsulated recombinant interleukin-2 |
|---|---|
| Trade Name | |
| Orphan Indication | Brain and CNS tumors |
| USA Market Approval | USA |
| USA Designation Date | 1991-11-25 00:00:00 |
| Sponsor | Oncothyreon Canada, Inc.;2011-94 St., NW, Suite 200; |